Anteris (TAVR) Advisory Board member Dr Jeffrey Popma
Posted on 20 May 2020 in Cardiovascular News
Medtronic has that announced Jeffrey J Popma (Harvard Medical School; Beth Israel Deaconess Medical Center, Boston, USA) will join the company as vice president and chief medical officer supporting the coronary, renal denervation, and structural heart businesses. A press release reports that Popma will serve as a strategic adviser for cardiovascular device innovation, and assist in the development of an expanding clinical research portfolio, leveraging his deep expertise in interventional cardiology and transcatheter-based therapies.
https://cardiovascularnews.com/jeffrey-j-popma-joins-medtronic-as-vice-president-and-chief-medical-officer-for-coronary-renal-denervation-and-structural-heart-businesses/
Cardiovascular News
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |